SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-10-097867
Filing Date
2010-10-29
Accepted
2010-10-29 09:15:32
Documents
13
Period of Report
2010-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q c60891e10vq.htm 10-Q 402052
2 EX-10 c60891exv10.htm EX-10 58580
3 EX-11 c60891exv11.htm EX-11 10308
4 EX-12 c60891exv12.htm EX-12 10105
5 EX-31.1 c60891exv31w1.htm EX-31.1 8673
6 EX-31.2 c60891exv31w2.htm EX-31.2 9696
7 EX-32 c60891exv32.htm EX-32 4561
  Complete submission text file 0000950123-10-097867.txt   7249449

Data Files

Seq Description Document Type Size
8 EX-101 INSTANCE DOCUMENT lly-20100930.xml EX-101.INS 1033823
9 EX-101 SCHEMA DOCUMENT lly-20100930.xsd EX-101.SCH 37696
10 EX-101 CALCULATION LINKBASE DOCUMENT lly-20100930_cal.xml EX-101.CAL 48479
11 EX-101 LABELS LINKBASE DOCUMENT lly-20100930_lab.xml EX-101.LAB 276441
12 EX-101 PRESENTATION LINKBASE DOCUMENT lly-20100930_pre.xml EX-101.PRE 192242
13 EX-101 DEFINITION LINKBASE DOCUMENT lly-20100930_def.xml EX-101.DEF 93758
Mailing Address LILLY CORPORATE CENTER DROP CODE 1112 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1112 INDIANAPOLIS IN 46285 3172762000
LILLY ELI & CO (Filer) CIK: 0000059478 (see all company filings)

IRS No.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-06351 | Film No.: 101149876
SIC: 2834 Pharmaceutical Preparations